Bharat Biotech slows down Covaxin production for facility optimisation - Moneycontrol

The company to focus on pending facility maintenance, process and facility optimisation activities.

Bharat Biotech on April 1 announced the temporary slowing down of production of its COVID-19 vaccine Covaxin across its manufacturing facilities, having completed its supply obligations to procuremen… [+2276 chars]

full article...